A Phase 2a Study to Assess Safety, Daily Symptoms, PK, and Biomarkers of YPL-001 in COPD Patients

Clinical trial NCT02272634 · COMPLETED

Trial details

NCT number: NCT02272634
Sponsor: Yungjin Pharm. Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease

Start date: 2015-06-04
Primary completion: 2017-11-08
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.